Evaluating Autologous Serum Skin Test for Early Detection of Auto-Antibodies in Chronic Urticaria
Abstract
Chronic urticaria (CU) is a condition characterized by recurrent hives and itching lasting longer than six weeks, often with an unclear etiology. Autoimmune mechanisms have been implicated in a significant proportion of CU cases, yet reliable methods for identifying auto-antibodies are still evolving. This study evaluates the effectiveness of the autologous serum skin test (ASST) as a preliminary tool for detecting auto-antibodies in patients with chronic urticaria. The ASST involves intradermal injection of the patient's own serum, with a positive reaction indicating the presence of auto-antibodies that may contribute to the disease.
In this study, we recruited 50 patients diagnosed with chronic urticaria, administering the ASST and analyzing the correlation between test results and clinical features. The test's sensitivity, specificity, and predictive values were calculated, and results were compared with other diagnostic methods, including indirect immunofluorescence assays for specific auto-antibodies. Our findings demonstrate that the ASST is a valuable initial screening tool, showing significant concordance with other diagnostic methods and correlating well with clinical severity.
The study concludes that the ASST is a practical and cost-effective method for early detection of auto-antibodies in chronic urticaria. Its implementation can guide further diagnostic evaluation and inform therapeutic strategies, offering a more streamlined approach to managing this complex condition. Future research should focus on validating the ASST's role in larger, diverse populations and exploring its potential for routine clinical use.
Keywords
autologous serum skin test, chronic urticaria, auto-antibodies, early detection, diagnostic testHow to Cite
References
Nettis E, Pannofino A, D’Aprile C, Ferrannini A, Tursi A. Clinical and aetiological aspects in urticaria and angio-oedema.Br. J. Dermatol. 2003;148(3):501–506.
Urticaria. In: James W D, Berger T G, Elston D M, editors Andrews’ Diseases of the Skin: Clinical Dermatology, 12th ed. Philadelphia: Elsevier 2016:p146.
The Skin in Immune, Autoimmune, Autoinflammatory and Rheumatic Disorders. In: Wolff K, Johnson R A, Saavedra A P, Roh E K, editors. Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology, 7th ed. Mc Grew Hill: New York,2013:p.309.
Caproni M, Giomi B, Volpi W, Melani L, Schincaglia E, Macchia D, et al. Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals. Clin immunol 2005;114(3):284-92.
Grattan CE, Wallington TB, Warin RP, Kennedy CT, Lbradfield JW. A serological mediator in chronic idiopathic urticaria—a clinical, immunological and histological evaluation. British Journal of Dermatology. 1986;114(5):583-90.
Grattan CE, Sabroe RA, Greaves MW. Chronic urticaria. J Am Acad Dermatol. 2002;46(5):645-57; quiz 657-60.
Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screen-ing test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999;140:446-52.
Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-Fc ep-silon RI or anti-IgE autoantibodies. J Am Acad Dermatol 1999;40:443-50.
Krause K, Metz M, Magerl M, Maurer M. Prevalence and relevance of skin autoreactivity in chronic urticaria. Expert Review of Dermatology. 2009;4(6):655-63.
Caproni M, Volpi W, Giomi B, Cardinali C, Antiga E, Melani L, et al. Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol 2004;84:288-90.
Godse KV. Autologous serum skin test in chronic idiopathic urticaria. Indian Journal of Dermatology, Venereology and Leprology. 2004;70(5):283.
Copyright (c) 2024 Mashaekh Banik, Shamim Mohammad Khan (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
